Your browser doesn't support javascript.
loading
The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity.
Torres-Perez, Elena; Valero, Monica; Garcia-Rodriguez, Beatriz; Gonzalez-Irazabal, Yolanda; Calmarza, Pilar; Calvo-Ruata, Luisa; Ortega, Carmen; Garcia-Sobreviela, Maria Pilar; Sanz-Paris, Alejandro; Artigas, Jose Maria; Lagos, Javier; Arbones-Mainar, Jose M.
Afiliación
  • Torres-Perez E; Adipocyte and Fat Biology Laboratory (AdipoFat), Unidad de Investigación Traslacional, Hospital Universitario Miguel Servet, Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain. etorresp.iacs@aragon.es.
  • Valero M; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain. etorresp.iacs@aragon.es.
  • Garcia-Rodriguez B; Unidad de Cirugía, Hospital Royo Villanova, Zaragoza, Spain. mvalsaba@hotmail.com.
  • Gonzalez-Irazabal Y; Servicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, Zaragoza, Spain. bea_garcia_rodriguez@hotmail.com.
  • Calmarza P; Servicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, Zaragoza, Spain. yolgonira@gmail.com.
  • Calvo-Ruata L; Servicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, Zaragoza, Spain. mpcalmarza@salud.aragon.es.
  • Ortega C; Servicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, Zaragoza, Spain. mlcalvo@salud.aragon.es.
  • Garcia-Sobreviela MP; Servicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, Zaragoza, Spain. cortegama@salud.aragon.es.
  • Sanz-Paris A; Adipocyte and Fat Biology Laboratory (AdipoFat), Unidad de Investigación Traslacional, Hospital Universitario Miguel Servet, Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain. jmarbones.iacs@aragon.es.
  • Artigas JM; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain. jmarbones.iacs@aragon.es.
  • Lagos J; Servicio de Endocrinología y Nutrición, Hospital Universitario Miguel Servet, Zaragoza, Spain. sanzparisalejandro@gmail.com.
  • Arbones-Mainar JM; Servicio de Radiodiagnóstico, Hospital Universitario Miguel Servet, Zaragoza, Spain. jmartigasm@gmail.com.
Cardiovasc Diabetol ; 14: 40, 2015 Apr 22.
Article en En | MEDLINE | ID: mdl-25896263
ABSTRACT

BACKGROUND:

Obesity is an excessive accumulation of fat frequently, but not always, associated with health problems, mainly type 2 diabetes and cardiovascular disease. During a positive energy balance, as caused by excessive intake or sedentary lifestyle, subcutaneous adipose tissue expands and accumulates lipids as triglycerides. However, the amount of adipose tissue per se is unlikely to be the factor linking obesity and metabolic complications. The expandability hypothesis states that, if this positive energy balance is prolonged, a point is eventually reached where subcutaneous adipose tissue can not further expand and energy surplus no longer can be safely stored. Once the limit on storage capacity has been exceeded, the dietary lipids start spilling and accumulate ectopically in other organs (omentum, liver, muscle, pancreas) forming lipid byproducts toxic to cells. METHODS/

DESIGN:

FATe is a multidisciplinary clinical project aimed to fill gaps that still exist in the expandability hypothesis. Imaging techniques (CT-scan), metabolomics, and transcriptomics will be used to identify the factors that set the limit expansion of subcutaneous adipose tissue in a cohort of caucasian individuals with varying degrees of adiposity. Subsequently, a set of biomarkers that inform the individual limits of expandability will be developed using computational and mathematical modeling. A different validation cohort will be used to minimize the risk of false positive rates and increase biomarkers' predictive performance.

DISCUSSION:

The work proposed here will render a clinically useful screening method to predict which obese individuals will develop metabolic derangements, specially diabetes and cardiovascular disease. This study will also provide mechanistic evidence that promoting subcutaneous fat expansion might be a suitable therapy to reduce metabolic complications associated with positive energy balance characteristic of Westernized societies.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus / Metabolismo Energético / Grasa Subcutánea / Adiposidad / Obesidad Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus / Metabolismo Energético / Grasa Subcutánea / Adiposidad / Obesidad Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: España